The veterinary vaccines markets in Africa and the Middle East will grow rapidly to a peak of 7.1% annually by 2022 due to several factors linked to the rising prevalence of animal diseases.

In a new report that examines trends in Africa and the Middle East’s vaccines markets between 2018 and 2002, Market Research Future says the bovine vaccines segment will register higher demand growth due to the organised nature of the beef and dairy industries.

Trends including increased emphasis on technology, the rise of recombinant DNA vaccines and better buying power of the livestock industry are also rated among the key drivers of the anticipated growth.

Drivers also include environmental conditions in Africa, the presence of wild animals in close proximity to human habitation that favours disease transmission, the growing number of pet owners and the entry of China into the vaccine manufacturing market, says the report.

Also read: FAO seeks funds for urgent livestock vaccination in South Sudan

However, the market is seen as constrained by tough competition from the European dairy and meat industry, the rearing of low yielding animals that do not provide incentives to vaccination, and the inability to manage the side-effects of vaccination.

Lack of vaccines awareness, few government programs for livestock vaccination as compared to human vaccination, variations in vaccine effectiveness and efficacy, and low per capita income are also seen as likely to retard the growth of the African and Middle Eastern vaccines markets.

However, the report said dealers would remain in profit because globally, vaccines are still considered as the most effective method of disease prevention.

Also read:
Global FMD vaccines may grow more than 10% over the next 4 years
£90m for development of “super-crops” and livestock vaccines for Africa